Availability of results from clinical research: Failing policy efforts

Journal of Epidemiology and Global Health

Volumn 4, Issue 1, 2014, Pages 1-12

  Shamliyan, Tatyana A ^a,b,c   Kane, Robert L ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minnesota Evidence based Practice Center   (United States)

^c ELSEVIER MASSON   (France)

Author keywords

Clinical epidemiology; Clinical research Standards; Evidence based medicine; Publication bias

Indexed keywords

ACCESS TO INFORMATION; AGE DISTRIBUTION; ARTICLE; CLINICAL RESEARCH; DECISION MAKING; EVIDENCE BASED PRACTICE; FUNDING; HUMAN; MEDICAL RECORD; NON PROFIT ORGANIZATION; POLICY; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; SOCIAL PARTICIPATION; STUDY DESIGN; CLINICAL TRIAL (TOPIC); ETHICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; MEDICAL RESEARCH; MEDLINE; MULTIVARIATE ANALYSIS; REGISTER; STANDARDS; STATISTICS AND NUMERICAL DATA;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HEALTH POLICY; HUMANS; MULTIVARIATE ANALYSIS; PUBLICATIONS; PUBMED; REGISTRIES; RESEARCH SUPPORT AS TOPIC;

EID: 84893964433     PISSN: 22106006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jegh.2013.08.002     Document Type: Article

References (39)

1. Clancy C.M., Slutsky J.R., Patton L.T. Evidence-based health care 2004: AHRQ moves research to translation and implementation. Health Serv Res 2004, 39(5):xv-xxiii.
2. Kaiser J.U.S. Budget 2009. NIH hopes for more mileage from roadmap. Science 2008, 319(5864):716.
3. Loscalzo J. The N.I.H. budget and the future of biomedical research. N Engl J Med 2006, 354(16):1665-1667.
4. Steinbrook R. The N.I.H. stimulus - the recovery act and biomedical research. N Engl J Med 2009, 360(15):1479-1481.
5. Slutsky J.R., Clancy C.M. The Agency for Healthcare Research and Quality's Effective Health Care Program: creating a dynamic system for discovering and reporting what works in health care. Am J Med Qual 2005, 20(6):358-360.
6. Hopewell S., Loudon K., Clarke M.J., Oxman A.D., Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009, 1. [MR000006].
7. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA 1990, 263(10):1385-1389.
8. Dickersin K. How important is publication bias? A synthesis of available data. AIDS Educ Prev 1997, 9(Suppl. 1):15-21.
9. Dickersin K., Min Y.I. Publication bias: the problem that won't go away. Ann N Y Acad Sci 1993, 703:135-146.
10. Ioannidis J.P. Why most published research findings are false: author's reply to Goodman and Greenland. PLoS Med 2007, 4(6):e215.
11. Food and Drug Administration. Modernization Act (FDAMA) Pub L No. 105-115, 111 1997; Stat 2296, 2310(113).
12. Zarin D.A., Keselman A. Registering a clinical trial in ClinicalTrials.gov. Chest 2007, 131(3):909-912.
13. Zarin D.A., Ide N.C., Tse T., Harlan W.R., West J.C., Lindberg D.A. Issues in the registration of clinical trials. JAMA 2007, 297(19):2112-2120.
14. Zarin D.A., Tse T., Ide N.C. Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 2005, 353(26):2779-2787.
15. World Association of Medical Editors (WAME) Editorial Policy Committee. The Registration of, Clinical Trials; 2005.
16. Food and Drug Administration. Amendments Act of 2007. Pub L No. 110-85, 121 Stat 823, 904, Title VIII (September 27, 2007), 42 USC 282(j) (Supp. 2009); 2010.
17. Ross J.S., Tse T., Zarin D.A., Xu H., Zhou L., Krumholz H.M. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 2012, 344:d7292.
18. Shamliyan T., Kane R.L. Clinical research involving children: registration, completeness, and publication. Pediatrics 2012, 129(5):e1291-e1300.
19. Shamliyan T.A., Kane R.L., Wyman J., Sainfort F. Results availability from clinical research of female urinary incontinence. Neurourol Urodyn 2012, 31(1):22-29.
20. Zarin D.A., Tse T., Williams R.J., Califf R.M., Ide N.C. The ClinicalTrials.gov results database - update and key issues. N Engl J Med 2011, 364(9):852-860.
21. Huser V., Cimino J.J. Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials. PLoS One 2013, 8(7):e68409.
22. Williams R.J., Tse T. New look for ClinicalTrials.gov. NLM Tech Bull 2007, (358):e2.
23. Allison P.D. Survival analysis using SAS Cary 2010, NC, SAS Institute. 2nd ed.
24. Prayle A.P., Hurley M.N., Smyth A.R. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 2012, 344:d7373.
25. Ross J.S., Mulvey G.K., Hines E.M., Nissen S.E., Krumholz H.M. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 2009, 6(9):e1000144.
26. Shamliyan TA, Wang SY, Olson-Kellogg B, Kane RL. Physical Therapy interventions for knee pain secondary to osteoarthritis Rockville (MD): Agency for Healthcare Research and Quality (US). Report No.: 12(13)-EHC115-EF. (AHRQ Comparative Effectiveness Reviews); 2012.
27. van de Wetering F.T., Scholten R.J., Haring T., Clarke M., Hooft L. Trial registration numbers are underreported in biomedical publications. PLoS One 2012, 7(11):e49599.
28. Scherer R.W., Sieving P.C., Ervin A.M., Dickersin K. Can we depend on investigators to identify and register randomized controlled trials?. PLoS One 2012, 7(9):e44183.
29. The World Health Organization. International Clinical Trials Registry Platform; 2010.
30. Mullan R.J., Flynn D.N., Carlberg B., Tleyjeh I.M., Kamath C.C., LaBella M.L., et al. Systematic reviewers commonly contact study authors but do so with limited rigor. J Clin Epidemiol 2009, 62(2):138-142.
31. Bourgeois F.T., Murthy S., Mandl K.D. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010, 153(3):158-166.
32. Mathieu S., Boutron I., Moher D., Altman D.G., Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009, 302(9):977-984.
33. Drazen J.M. Transparency for clinical trials - the TEST Act. N Engl J Med 2012, 367(9):863-864.
34. Institute of Medicine (U.S.). Sharing Clinical Research Data - Workshop Summary. Washington, DC: Institute of Medicine of the National Academies; 2013.
35. Shamliyan T.A., Kane R.L. Incomplete and unreported: failure to report results of incomplete studies results in publication bias. Am J Bioethics 2012, 3(4):1-18.
36. Moja L.P., Moschetti I., Nurbhai M., Compagnoni A., Liberati A., Grimshaw J.M., et al. Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials 2009, 10:56.
37. Avanesova AA. Stavropol State University, Clinical research in Russia - Regulations and trends. International Conference and Exhibition on Pharmacovigilance & Clinical Trials, Hosted by the OMICS Group, October 1-3, 2012, Chicago, USA, Clinical and experimental pharmacology (2). [accessed in August 2013]. http://www.omicsonline.org/pharmacovigilance2/poster-presentations.php.
38. Avanesova AA. Availability of the results from registered clinical studies enrolling Russian subjects Presented in the 2nd World Drug Discovery Online Conference, October 16-18, 2012, [accessed in August 2013]. http://targetmeeting.com/Modules/Meetings/MeetingDetails.aspx?Id=45.
39. Chalmers I., Glasziou P., Godlee F. All trials must be registered and the results published. BMJ 2013, 346:f105.